Small molecule research compound
Transtorine (also known as kynurenic acid) is a small molecule currently being studied in early-stage research. It is not an approved medication for any specific condition at this time.
How it worksThe specific way this molecule works in the body is not yet fully established for clinical use, but it is being researched for its biological activities.
How to take
Transtorine is currently in the research phase (Max Phase 1) and is not available for consumer use as a prescribed drug or over-the-counter medication. Information regarding human dosing and administration is not available in the provided data bundle. Information is based on chemical research profiles and toxicity studies rather than clinical drug labels. Any mention of its properties is based on laboratory testing (in vitro/in silico).
Side effects
Serious
- ·Eye irritation has been noted in laboratory studies.
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
